1841-1860 of 2147 < first | | | last >
  • BMS, CBS Focus on PAT to Save Biopharm Big Bucks

    In September, a new Center for Bioanalytical Sciences will start up, involving Bristol-Myers Squibb Co., Dublin City University and the National University of Ireland, Galway. BMS predicts the technologies being developed could reduce biopharmaceutical production costs by $80 million per year for a typical medium to large processing line.

    Agnes Shanley, Editor in Chief
  • Plug and Play PAT, Anyone?

    A common user interface, and “out of the box” software will be essential to driving PAT in the pharmaceutical industry, say Pfizer’s control and IT experts Velumani Pillai and Martin Warman. They’re developing a template for IT requirements and seek input from vendors and other users.

    Velumani Pillai and Martin Warman, Pfizer, Inc.
  • Ending the Paper Chase

    Pioneers are taking e-notebooks beyond the R&D lab.

    Angelo De Palma, Ph.D., Contributing Editor
  • On the Trail of the Celtic Tiger

    Ireland’s pharmaceutical base faces stiff competition from lower cost centers, but it’s clearly on the leading edge.

    Agnes Shanley, Editor in Chief
  • Grooming the Celtic Tiger for Drugmaking Dominance

    In this audio interview, Niall O'Donnellan, manager of life sciences and chemicals at Enterprise Ireland discusses developments in pharmaceutical manufacturing on the Emerald Isle. Enterprise Ireland is the government agency charged with stimulating entrepreneurship and the development of new companies in Ireland.

    Agnes Shanley, Editor in Chief
  • It's a Small(er) World

    Nanotechnology developments illustrate the potential of miniaturization to transform the pharmaceutical industry.

    Gregg Carlstrom, Assistant Editor
  • RFID: Where Do We Stand?

    RFID has been a hot topic of conversation, thanks to the mega-retailers, the DOD and the FDA. But actual adoption of the technology has been tepid at best.

    Bert Moore, AIM Global
  • The State of E-Pedigree Laws

    Coming to a state near you, laws which require certified drug authentication.

    Peter Spellman, Senior VP of Products and Services, and Brenda Kelly, VP of Marketing and Regulatory Affairs, SupplyScape, Inc.
  • Inching Closer to Plug-and-Play RFID

    'Plug-and-play' solutions may never arrive, but RFID analyst Sara Shah says equipment manufacturers are on the cusp of viable offerings that will vastly simplify RFID implementations.

1841-1860 of 2147 < first | | | last >